Join to view full profile
1230 York Ave# 39New York, NY 10065
Phone+1 212-327-7858
Fax+1 212-327-7319
Dr. Davidson-Moncada is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Royal Free Hospital and University College London Medical SchoolClass of 2002
Clinical Trials
- MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer Start of enrollment: 2018 Jun 04
Publications & Presentations
PubMed
- 6 citationsMyeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia.Ibrahim Aldoss, Parastou Tizro, Davsheen Bedi, James K Mangan, Mary C Clark
Haematologica. 2023-12-01 - 13 citationsExpanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations.David S J Allan, Chuanfeng Wu, Ryland D Mortlock, Mala Chakraborty, Katayoun Rezvani
Molecular Therapy Oncolytics. 2023-03-16 - 5 citationsEfficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia.Sonali P Barwe, Anne Kisielewski, Ezio Bonvini, John Muth, Jan Davidson-Moncada
Journal of Clinical Medicine. 2022-02-28
Abstracts/Posters
- A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART¬ Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid LeukemiaJan K Davidson-Moncada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Flotetuzumab (FLZ), an Investigational CD123 x CD3 Bispecific Dart¬ Protein-Induced Clustering of CD3+ T Cells and CD123+ AML Cells in Bone Marrow Biopsies Is Associat...Jan K Davidson-Moncada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Effect of Ara-C on T-Cell Function and Flotetuzumab Activity in Pediatric Acute Myeloid LeukemiaJan K Davidson-Moncada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Key Oncology Drugs Granted FDA Designations in January 2026February 3rd, 2026- Wugen Presents Data on WU-NK-101 in Combination with Cetuximab in Preclinical Models of Advanced Colorectal Cancer (CRC) at ASCO Gastrointestinal Cancers SymposiumJanuary 21st, 2023
- Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed/Refractory AML at American Society of Hematology (ASH) 64th Annual MeetingDecember 11th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
